- Nitric oxide (NO) is involved in an array of physiological processes that regulate skeletal muscle function. Dietary nitrate supplementation increases plasma nitrite concentration and therefore NO bioavailability. Nitrate supplementation may enhance exercise economy and performance, although its efficacy appears to be related both to the endurance training status of the participants and to the type of exercise being performed.
- We present evidence that nitrate supplementation may be particularly effective at augmenting physiological responses in type II (fast-twitch) muscle. The relatively low O2 tension surrounding type II fibers may promote the reduction of nitrite to NO, thereby improving: local perfusion, fatigue resistance, fiber contractility and, ultimately, whole body exercise performance.
- This targeted effect of nitrate supplementation on type II muscle may have important implications for improving performance during high-intensity (intermittent) exercise in healthy adults and for helping to restore functional capacity in senescent and patient populations where increased reliance on type II muscle fibers contributes to compromised exercise tolerance.
Nitric oxide (NO) is essential to life. It is a gaseous signaling molecule that is produced continuously to enable or facilitate a wide range of physiological processes including neurotransmission, vasodilatation, angiogenesis, cellular respiration, mitochondrial biogenesis, and muscular contraction. A failure to produce or use sufficient NO occurs in senescence and is a characteristic of many cardiovascular and metabolic diseases. The production of NO often is attributed exclusively to the canonical pathway in which the semi-essential amino acid l-arginine is oxidized in a reaction catalyzed by the NO synthase (NOS) family of enzymes. The products of this reaction, nitrite (NO2−) and nitrate (NO3−), were thought originally to have no physiological relevance. However, it is now appreciated that, under certain physiological conditions (e.g., in low-O2 environments that may exist in some tissues such as contracting skeletal muscle), NO2− may undergo a one-electron reduction to re-form NO.
Dietary supplementation with the NOS pathway substrate, l-arginine, seems to have a very limited effect on NO-related physiological processes (37). In contrast, consuming foodstuffs such as green leafy vegetables (spinach, lettuce, rocket/arugula) and beetroot, which are rich in inorganic NO3−, substantially increases the circulating plasma [NO3−] and [NO2−], thereby increasing the potential for O2-independent NO synthesis (24). A crucial step in this NO3−-NO2−-NO pathway is the conversion of NO3− to NO2− by facultative bacteria residing in the mouth. It has been shown repeatedly that dietary NO3− intake results in a significant reduction of resting blood pressure for several hours, consistent with an NO-mediated peripheral vasodilatation. Other physiological effects of NO3− ingestion also have been reported, including a reduction in the O2 cost of submaximal exercise, at least in nonelite athletes ((2,4,22,23) cf. (19)). This effect, which may arise as a consequence of a reduced adenosine triphosphate (ATP) cost of muscle force production (2) or to enhanced mitochondrial efficiency (22), is surprising given that this variable has been considered to be essentially unaltered by factors such as subject health and age, as well as aerobic fitness and training status, at least for cycle exercise. Improved muscle efficiency and/or exercise economy would be anticipated to result in enhanced exercise performance, and this has led to many recreational and elite athletes consuming NO3−-rich products, usually beetroot juice, precompetition and/or to support training (18). However, although NO3− supplementation has been reported to be performance enhancing in multiple studies involving recreationally active or moderately trained subjects (e.g., (2,4,41,42)), it seems that elite endurance athletes do not benefit to the same extent (e.g.,6,9, see 18 for review).
Although there are several factors that might explain the difference in responsiveness to NO3− supplementation between elite and nonelite subjects, including dose and duration of NO3− supplementation as well as genetic or training effects on NOS activity, muscle oxygenation, and mitochondrial function, likely differences in muscle fiber type composition between these populations also might be important (18). Although there is considerable heterogeneity both between and within muscle fiber types, compared with Type I (slow-twitch) fibers, Type II (fast-twitch) fibers differ in terms of myofibrillar protein content and calcium handling, typically have lower mitochondrial and capillary density, and, therefore, rely relatively more on nonoxidative compared with oxidative pathways of ATP resynthesis (7). The lower O2 availability in Type II muscle, reflected in O2 tension (PO2), in addition to possible differences in contractile function and efficiency characteristics, results in greater fatigability compared with Type I muscle. The predominant muscle fiber type in a given muscle reflects its function. For example, across muscles in the human leg, the soleus may be approximately 88% Type I fibers, whereas the rectus femoris may be only approximately 35% Type I fibers (17). Moreover, in elite athletes, endurance runners may have approximately 70% Type I fibers whereas sprinters may have approximately 40% Type I fibers in the quadriceps femoris (33).
In this article, we explore the hypothesis (schematized in Fig. 1) that the efficacy of dietary NO3− supplementation may be linked to specific physiological effects on Type II muscle fibers.
PHYSIOLOGICAL HYPOXIA AND THE EFFICACY OF NITRATE SUPPLEMENTATION
Because our hypothesis that Type II muscle fibers may be especially targeted by NO3− supplementation rests, at least in part, on differences in intramyocyte PO2 between fiber types, we first consider the role of systemic and local O2 availability on NO production and the efficacy of NO3− supplementation on physiological function in hypoxia.
Nitric oxide bioavailability and bioactivity are dictated by an intricate balance between NO and O2. Dependent on the metabolic rate and the matching of tissue O2 delivery (Q˙O2), PO2 fluctuates from approximately 40 mm Hg (5% O2) at rest to as low as approximately 2 mm Hg (∼0.4% O2) during strenuous exertion (32). Nitric oxide production via NOS enzymes requires the presence of O2. Given the role of NO as a master regulator of blood flow and cellular respiration, it is intuitive that a backup system is needed to guarantee NO bioavailability under the low-PO2 conditions, which are native to skeletal muscle. Indeed, NO can be produced alternatively via the NOS-independent, single-electron reduction of NO2−, which is obtained through dietary NO2− and NO3− as well as via oxidation of endogenous NO (24). Importantly for maintenance of NO bioavailability, NO2− reduction to NO is stimulated by low PO2 and low pH (24). Therefore, the therapeutic potential of the NO3− reduction pathway to compensate for dysfunctional NOS is substantial.
There is convincing evidence from in vitro experiments that physiologically critical NO-mediated signaling pathways that regulate skeletal muscle Q˙O2 and cellular bioenergetics are O2 dependent (35). Low physiological PO2 in active muscle stimulates erythrocyte-derived NO-mediated vascular relaxation, which serves to match Q˙O2 to local metabolic rate, whereas high PO2 triggers vasoconstriction. NO regulates myocyte calcium flux via S-nitrosylation of thiols contained in ryanodine receptor (RyR1) Ca2+ channels. These are activated only only by NO at low physiological PO2 (∼10 mm Hg), such that low PO2 in active muscle increases contractility, and high physiological PO2 has the opposite effect. NO also may regulate mitochondrial respiration by reversible inhibition of cytochrome c oxidase in competition with O2, such that greater inhibition by NO would occur at low physiological PO2. It has been proposed that, collectively, the actions of NO2− and/or NO on O2 consumption and vasodilatation might enable a more precise local matching of blood flow to metabolic rate (35). It is important to note here that although it is likely that the effects of dietary NO3− largely are mediated by NO, it is possible that NO2− and/or other bioactive NO3−-derived molecules also play a role in the physiological effects observed after NO3− supplementation (1).
Restricted Q˙O2 to skeletal muscle reduces maximal oxidative metabolic rate (Qmax), which is reflected in a slowing of muscle phosphocreatine (PCr) recovery kinetics after exercise. For the same metabolic rate, there is a greater muscle metabolic perturbation (e.g., greater fall in muscle PCr concentration during exercise performed in hypoxia compared with normoxia). In vivo evidence suggests that the O2 demand of exercising muscle may be reduced during normoxic exercise after dietary NO3− supplementation ((2,4,22,23,36) cf. (19)), which might be consequent to an increased phosphate/oxygen ratio of mitochondrial respiration (22) and/or a reduced ATP cost of force production (2). Given that NO (and/or NO2−) has the potential to improve Q˙O2 as well as reduce the O2 demand for a fixed work rate, dietary NO3− supplementation might be particularly important for improving skeletal muscle functional capacity under conditions where O2 availability is low, irrespective of whether this is considered in terms of environmental, systemic, or local tissue O2 availability.
The influence of dietary NO3− on exercise tolerance in healthy humans under hypoxic conditions has been investigated using manipulation of the inspired O2 fraction. It was first shown that 24 h of NO3− supplementation (9.3 mmol·NO3−) reduced the extent of muscle metabolic perturbation during high-intensity knee-extension exercise and enhanced exercise tolerance in moderate hypoxia (14.5% O2) ((38) Fig. 2). Dietary NO3− supplementation also abolishes the reduction in the rate of pH-independent PCr recovery, which typically is observed in hypoxia, and essentially restores muscle Qmax to values similar to those observed in normoxia ((38,39) Fig. 2). The speeding of Cr recovery was linked to improved muscle oxygenation during the immediate postexercise period in hypoxia but not in normoxia (assessed using effective transverse relaxation time weighted magnetic resonance signal) in healthy young adults (39). These data, therefore, suggest that, in hypoxia, dietary NO3− supplementation may facilitate NO production and enable greater muscle oxygenation, offsetting the deleterious effects of hypoxia on muscle function.
During whole body exercise in hypoxia, NO3− supplementation has been shown to reduce the O2 cost of submaximal exercise by approximately 4% to 7% (19,25,27). Moreover, muscle oxygenation, defined as the total oxygenation index derived from near-infrared spectroscopy (NIRS), was elevated by 4% to 5% at rest and during both submaximal and maximal-intensity exercise after NO3− supplementation in hypoxia (11% O2) (25). This may reflect the lower V˙O2 observed (25) or be indicative of NO-mediated enhanced bulk Q˙O2 and/or microvascular O2 distribution during hypoxic exercise. These same factors may underpin the faster pulmonary V˙O2 kinetics after NO3− supplementation reported during exercise in hypoxia but not normoxia (19). Dietary NO3− ingestion also attenuated the hypoxia-induced reduction in exercise tolerance during both severe-intensity constant work rate exercise (by 9% (19)) and exhaustive incremental exercise (by 5% (25)). It seems that, for the same NO3− dose, NO3− supplementation is more effective during whole body exercise in hypoxia than in normoxia, with the improvement in high-intensity exercise tolerance being related to the reduced O2 cost of submaximal exercise (19) perhaps because this would permit a better preservation of arterial O2 saturation. Importantly, the beneficial effects by NO3− ingestion on exercise tolerance in hypoxia may translate to improved exercise performance; in one study, a 16.1-km cycling time trial performance was reported to be improved by approximately 2% by NO3− supplementation compared with placebo under 15% inspired O2 (27).
The available evidence indicates that elevating NO bioavailability through a simple dietary intervention may particularly be beneficial in hypoxic conditions such as occurs during exposure to high altitude and in conditions where Q˙O2 is impaired, including various cardiovascular, pulmonary, and sleep disorders. Although the potentially greater physiological effects of NO3− supplementation pertain to when an individual exercises at altitude or breathes a gas containing a low fraction of O2 at sea level (19), it is important to note that the ratio between local muscle blood flow and metabolic rate is heterogeneous even within skeletal muscle, and that Type II muscles and muscle fibers operate at a lower PO2 than do Type I muscles and muscle fibers (5,26). It, therefore, is conceivable that the physiological effects of NO2− are more manifest in Type II than Type I muscle. In the next section, we consider the potential influence of local hypoxia on NO bioavailability and the efficacy of NO3− supplementation.
MUSCLE FIBER TYPE SELECTIVITY OF NITRATE SUPPLEMENTATION: ANIMAL STUDIES
Skeletal muscles are highly heterogeneous in terms of their structure and function. For instance, muscle activation patterns, fatigability, fiber type composition, oxidative/glycolytic enzyme activities, vascularity, and vascular control broadly range among and within muscles (20). In humans, bipedalism has facilitated the additional flexibility of preferentially activating muscle groups in either the arms or legs and distributing the available (and potentially limited) cardiac output such that prodigious blood flows can be achieved when smaller muscle masses are activated. Through experimental evidence procured in humans, and especially animals, for the past few decades, our appreciation of heterogeneity with respect to blood flow among and within muscles has undergone a radical revision.
It is now recognized that both spatial and temporal heterogeneity of blood flow is of fundamental importance in the matching of increases in Q˙O2 to local metabolic requirements (V˙O2) (20). The ability to drive O2 from the capillary into the myocyte and, thus, to the mitochondria is dependent on the driving pressure (i.e., microvascular PO2, PmvO2) and the resultant pressure gradient. Because PmvO2 principally is determined by the Q˙O2/V˙O2 ratio and because PmvO2 determines blood-myocyte O2 flux and also influences metabolic control via intracellular PO2, it is intuitive that, unless Q˙O2/V˙O2 is regulated extremely tightly both spatially and temporally, V˙O2 kinetics may be slowed and muscle function will be suboptimal, thereby reducing exercise tolerance (30). By the same token, if the Q˙O2/V˙O2 ratio, and thus PmvO2, can be increased at any given work rate, exercise performance may be enhanced.
Dietary Nitrate Supplementation, Type II Muscle, and Fatigue
Exercise tolerance is dictated by a plethora of physiological and physiochemical interactions that ultimately determine the fatigability of skeletal muscle. Of the potential mechanisms of fatigue, the recruitment of higher-order motor units that elicit contraction of fast-twitch Type II muscles is especially pertinent herein. Muscles predominantly composed of Type II fibers regulate their PmvO2 very differently from their slow-twitch (Type I) counterparts. Specifically, significantly lower blood flow (relative to V˙O2) results in a much lower contracting PmvO2 (i.e., ∼10 vs 20 mm Hg; Fig. 1), ultimately forcing greater reliance on fractional O2 extraction in Type II compared with Type I muscle (5,26). The heterogeneous fiber type distribution evident in the rat and the ability to measure skeletal muscle vascular function across discrete muscle fiber types provide a powerful research tool to examine the impact of dietary NO3− on muscles of varying fiber type. It is important to note that human skeletal muscle also exhibits appreciable heterogeneity in fiber type (17,33), and that murine models may provide important insight into fiber-specific vascular control (20).
Given the propensity for a very low PO2 environment and possibly greater acidity to reduce NO2− to NO, Ferguson et al. (12) tested the hypothesis that dietary NO3− preferentially would increase blood flow and thus PmvO2 in exercising muscles composed of Type II fibers. In rats running at approximately 70% V˙O2max, beetroot juice ingestion (1 mmol·NO3−−1·kg−1 for 5 d) elevated blood flow to muscles and muscle portions composed of 66% or more Type II b+d/x muscle fibers (12) in concert with a lower blood lactate level. As expected, these selective vascular effects were found to raise PmvO2 in Type II, but not Type I, muscles during contractions (13) providing the mechanistic basis for the reduced blood lactate level (Fig. 1).
The preferential fiber type effects of NO3− supplementation is important for vascular control because NO synthesis via the NOS family of enzymes requires O2 and consequently may become dysfunctional at the low PO2 extant in contracting muscle. This may be especially true in Type II muscle given their inherently lower PO2 compared with Type I muscle (5,26). Thus, the reduction of NO2− to NO acts as a useful backup to maintain NO homeostasis and hyperemia in situations where NOS function is compromised. Indeed, it recently has been reported that bolus infusion of NO2− offsets acute pharmacological NOS inhibition and restores cardiovascular function to control values (11), thus supporting the complementary role of the NO3−-NO2−-NO pathway.
Another potential means by which dietary NO3− may elicit its beneficial effects involves its impact on skeletal muscle calcium-handling proteins. For instance, Hernández et al. (16) demonstrated that 7 d of supplementation with NO3−-enriched water resulted in an increased level of calsequestrin 1 and the dihydropyridine receptor, which ultimately increased the rate of muscle force development. Crucially, these effects were evident in the extensor digitorum longus (predominantly Type II) but not soleus (predominantly Type I) muscles, further supporting fiber type-specific effects of NO3− supplementation. Collectively, these results demonstrate that NO3− supplementation has the ability to impact skeletal muscle vascular and metabolic function during contractions, via both blood flow-dependent and -independent mechanisms.
From a performance standpoint, NO3−-targeted effects likely take center stage during high-intensity exercise given that Type II fibers are recruited to a greater extent in the heavy-intensity to severe-intensity exercise domains (21). These higher-intensity domains result in an increased V˙O2/Q˙O2 ratio (decreased Q˙O2/V˙O2 and PmvO2 (26)), which further exacerbates the tissue hypoxia within Type II muscles, ultimately resulting in increased accumulation of ADP, [Pi], [K+], and [H+], all of which are associated with fatigue development. As previously mentioned, these low-PO2/pH environments are ripe for reduction of NO2− to NO and thus likely facilitate the increase in Q˙O2 (and potentially reduced V˙O2) observed after NO3− supplementation. Moreover, the increased PmvO2 and any reduced V˙O2 may raise the intracellular PO2, which will act to reduce the intracellular perturbation of the aforementioned metabolites, thereby resulting in a tighter metabolic control. This is especially important when considering that increased intracellular PO2 reduces the ADP and nicotinamide adenine dinucleotide concentrations necessary to drive a given ATP production, consequently suppressing glycolysis and glycogen depletion. Finally, if Q˙O2 is limiting V˙O2 kinetics, it is quite possible that NO3− supplementation will help alleviate the O2 deficit by speeding V˙O2 kinetics in the first minutes of exercise (30).
ROLE OF TYPE II MUSCLE FIBER RECRUITMENT IN EFFICACY OF NITRATE SUPPLEMENTATION IN HUMANS
Since the seminal findings of Larsen et al. (23), most, although not all, studies have reported improvements in exercise economy and/or fatigue resistance in moderately trained participants (V˙O2peak, ≤55 mL·kg−1·min−1) after NO3− supplementation ((2,4,23,41) cf. (19)). Conversely, although some well-trained endurance athletes do exhibit improvements in exercise economy or performance, it seems that the ergogenicity of NO3− supplementation is attenuated in this population (e.g., (6,9)). These observations are encapsulated in the recent study by Porcelli et al. (31), in which NO3− supplementation lowered V˙O2 during moderate-intensity running and improved 3-km running performance in participants with low (V˙O2peak, <45 mL·kg−1·min−1) and moderate (V˙O2peak, <45–57 mL·kg−1·min−1), but not high (V˙O2peak, >63 mL·kg−1·min−1), aerobic fitness, with the reductions in moderate-intensity V˙O2 and 3-km completion time being positively correlated with V˙O2peak. As previously reviewed (18), many NO3− supplementation studies may not have provided a sufficient NO3− dose and/or duration of supplementation to elicit physiological effects (41). It is plausible that elite athletes, in whom NOS activity, plasma [NO2−], and muscle oxygenation will all be enhanced by intensive training, might benefit from greater and/or more protracted NO3− supplementation (18). However, given that high-level endurance athletes would, in general, be expected to have a lower percentage of Type II muscle fibers (33) and that NO3− treatment seems to preferentially augment physiological responses in Type II muscle fibers in animal models (as described in the previous section), it is tempting to speculate that the efficacy of NO3− supplementation to improve physiological and functional responses in human participants might be linked to the population of muscle fibers recruited during exercise. Accordingly, recent research has sought to elucidate the potential for preferential effects of NO3− on human Type II skeletal muscle in vivo.
Influence of Muscle Fiber Type on the Effectiveness of Nitrate Supplementation in Humans
To examine the potential for a greater effectiveness of NO3− supplementation in human Type II muscle, recent studies have used experimental models to capitalize on differences in the power-velocity relationship between fiber types and the hierarchical recruitment of fiber types as force requirements are increased. Bailey et al. (3) observed greater muscle oxyhemoglobin concentration using NIRS, faster pulmonary V˙O2 kinetics, and extended severe-intensity exercise tolerance (+22%) after NO3− supplementation when cycling at 115 rpm, but not 35 rpm (Fig. 3). These findings are consistent with other recent in vivo data that indicated that peak knee extensor torque was increased at an angular velocity of 360 degrees·s−1 but not at angular velocities of 90, 180, and 270 degrees·s−1 after NO3− supplementation (10). Assuming that the proportional contribution of Type II muscle fibers to force production is greater at higher contraction frequencies or velocities, these findings support the notion of enhanced Q˙O2 and/or contractile function of Type II muscle in vivo after NO3− supplementation (3,10), consistent with observations in murine models (12,13,16).
Further support for a targeted effect of NO3− ingestion on human Type II muscle was provided in the study by Breese et al. (8). These authors administered an initial step work rate increment from a low-intensity baseline (20 W) to a moderate-intensity work rate (<gas exchange threshold; L→M), where predominantly Type I muscle fibers are recruited (21), and a subsequent step to a severe-intensity work rate (>critical power; M→S), where a greater recruitment of Type II muscle fibers has been reported (21). These double-step tests were completed after both NO3− and placebo supplementation. Compared with placebo, NO3− resulted in faster pulmonary V˙O2 and muscle deoxyhemoglobin kinetics (reflective of faster muscle O2 extraction kinetics) in M→S but not L→M (Fig. 3). In addition, exercise tolerance during M→S was extended by 22% after NO3− compared with placebo ingestion. Although necessarily speculative, taken together, these findings suggest that the physiological effects evoked by NO3− supplementation may be enhanced in Type II muscle fibers.
It is well known that short-duration high-intensity intermittent exercise mandates a significant recruitment of Type II muscle fibers. Accordingly, improved performance during such exercise would be hypothesized if NO3− supplementation was particularly effective at augmenting physiological processes in Type II muscle. However, the effect of NO3− supplementation on performance during short-duration high-intensity intermittent exercise is controversial (9,28,34,40,42). From the existing studies, it seems that when participants received only an acute NO3− bolus (28), or when elite endurance cyclists completed repeated cycle sprints after 6 d of NO3− supplementation (9), performance was not enhanced. The lack of an ergogenic effect with NO3− supplementation in these studies might be attributable to an insufficient supplementation dose and/or duration to elicit the skeletal muscle and mitochondrial remodeling that underpins some of the positive physiological responses reported elsewhere (16,22) and to the lower percentage of Type II fibers in the locomotor muscles of elite endurance athletes (33). An interesting exception in this regard is that NO3− ingestion resulted in significantly improved exercise economy in a laboratory exercise test and significantly improved on-water time trial performance in elite kayakers (29). This is intriguing in relation to the hypothesis advanced in the current article because the upper body musculature typically has a higher fraction of Type II muscle fibers (17). However, other factors such as muscle volume, intramuscular tension, and perfusion pressure also may impact on the efficacy of NO3− supplementation in exercise of this type. On the other hand, when moderately trained team-sport athletes undergo short-term dietary NO3− supplementation, short-duration high-intensity intermittent exercise performance generally has been found to be enhanced (34,40,42). Although further research is required, initial observations support an ergogenic effect after short-term NO3− supplementation in moderately trained team-sport athletes, but not necessarily after acute NO3− ingestion and/or when elite endurance athletes complete short-duration high-intensity intermittent exercise.
Functional and Clinical Implications and Future Directions
The capacity to complete repeated bouts of high-intensity exercise is linked to the metabolic homeostasis of Type II muscle fibers and is an important determinant of performance in team sports. Therefore, the apparent improvements in pulmonary V˙O2 kinetics (3,8), skeletal muscle metabolic homeostasis (2,14), perfusion (12), oxygenation (3,13), force production (10,16), and fatigue resistance (2–4,8,34,42) with NO3− when Type II muscle fiber recruitment is likely to be greater might be expected to improve performance in team sports or other exercise settings that mandate a significant recruitment of Type II muscle. It also is noteworthy that many patient groups including those with peripheral artery disease, chronic obstructive pulmonary disease, and heart failure have a higher proportion of Type II muscle fibers (e.g., (15)). Given the emerging evidence to support augmented physiological benefits in Type II compared with Type I skeletal muscle, NO3− supplementation might represent a simple dietary intervention to improve skeletal muscle perfusion, contractile function, and fatigue resistance in some patient populations.
To further our understanding of these specific effects, future investigations using a multidisciplinary approach should resolve the impact of dietary NO3− supplementation on the Q˙O2/V˙O2 relationship across the spectrum of fast- versus slow-twitch muscles. In particular, simultaneous measurement of Q˙O2 and PO2mv (potentially by combining the phosphorescence quenching with the radiolabeled microsphere technique) in murine muscles of varying fiber type would afford calculation of skeletal muscle V˙O2 and shed further light on the impacts of NO3− supplementation on muscle vascular and metabolic control. In humans, important unresolved questions include whether 1) dietary NO3− supplementation increases skeletal muscle [NO3−] and [NO2−], 2) NO2− is “consumed” by contracting skeletal muscle (as determined by measurements of arterial-venous difference) and this correlates with changes in either Q˙O2 or V˙O2, 3) the energetics of isolated myocytes and/or mitochondria are altered on exposure to NO3− and NO2−, and 4) NO3− supplementation impacts the heterogeneity of local blood flow to metabolic rate as assessed with time-resolved multichannel NIRS (20). With specific regard to the potential fiber type sensitivity of NO3− supplementation highlighted in this article, future investigations might usefully compare the physiological responses to NO3− ingestion of athletes specializing in power and endurance sports (within whom fiber type distribution would be expected to be different) and/or characterize responders/nonresponders to NO3− supplementation on the basis of directly measured muscle fiber type.
Nitric oxide is involved in an array of physiological processes that regulate cardiovascular and muscle function. Because the activity of NOS can decline in low-O2 environments, various disease states, and in older age, the NO3−-NO2−-NO pathway represents an essential backup system for NO generation. Dietary NO3− supplementation increases plasma [NO2−] and therefore NO bioavailability. Assuming a sufficient dose and duration of supplementation, the effectiveness of NO3− in positively altering exercise economy and performance seems to be related both to the aerobic fitness or endurance training status of the subject population and to the type of exercise being considered (18). In this article, we have presented evidence consistent with the hypothesis that NO3− may be particularly effective at augmenting physiological responses in Type II muscle (Fig. 1). The relatively low PmvO2 therein may promote the reduction of NO2− to NO, thereby increasing local perfusion and Q˙O2/V˙O2, improving fatigue resistance, augmenting fiber contractility, and ultimately enhancing whole body exercise tolerance or performance. This targeted effect of NO3− supplementation on Type II muscle may have important implications for improving performance during intense exercise in healthy adults and for helping to restore functional capacity in senescent and patient populations, where increased reliance on Type II muscle fibers contributes to compromised aerobic capacity and exercise intolerance.
This study was supported by the National Heart, Lung, and Blood Institute grants HL-50306 and HL-108328.
A.M.J., A.V., and S.J.B. were supported, in part, by the Gatorade Sports Science Institute; D.C.P. was supported by a grant-in-aid from the American Heart Association.
1. Affourtit C, Bailey SJ, Jones AM, Smallwood MJ, Winyard PG. On the mechanism by which dietary nitrate improves human skeletal muscle function. Front Physiol.
2015; 6: 211.
2. Bailey SJ, Fulford J, Vanhatalo A, et al. Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans. J. Appl. Physiol
. 2010; 109: 135–48.
3. Bailey SJ, Varnham RL, DiMenna FJ, et al. Inorganic nitrate supplementation improves muscle oxygenation, O2
uptake kinetics, and exercise tolerance at high but not low pedal rates. J. Appl. Physiol
. 2015; 118: 1396–405.
4. Bailey SJ, Winyard P, Vanhatalo A, et al. Dietary nitrate supplementation reduces the O2
cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J. Appl. Physiol
. 2009; 107: 1144–55.
5. Behnke BJ, McDonough P, Padilla DJ, Musch TI, Poole DC. Oxygen exchange profile in rat muscles of contrasting fibre types. J. Physiol.
2003; 549: 597–605.
6. Bescós R, Ferrer-Roca V, Galilea PA, et al. Sodium nitrate supplementation does not enhance performance of endurance athletes. Med. Sci. Sports Exerc.
2012; 44: 2400–9.
7. Bottinelli R, Reggiani C. Human skeletal muscle fibres: molecular and functional diversity. Prog. Biophys. Mol. Biol.
2000; 73: 195–262.
8. Breese BC, McNarry MA, Marwood S, Blackwell JR, Bailey SJ, Jones AM. Beetroot juice supplementation speeds O2
uptake kinetics and improves exercise tolerance during severe-intensity exercise initiated from an elevated metabolic rate. Am. J. Physiol. Regul. Integr. Comp. Physiol.
2013; 305: R1441–50.
9. Christensen PM, Nyberg M, Bangsbo J. Influence of nitrate supplementation on VO2
kinetics and endurance of elite cyclists. Scand. J. Med. Sci. Sports
. 2013; 23: e21–31.
10. Coggan AR, Leibowitz JL, Kadkhodayan A, et al. Effect of acute dietary nitrate intake on maximal knee extensor speed and power in healthy men and women. Nitric Oxide
. 2015; 48: 16–21.
11. Ferguson SK, Glean AA, Holdsworth CT, et al. Skeletal muscle vascular control during exercise: impact of nitrite infusion during nitric oxide synthase inhibition in healthy rats. J. Cardiovasc. Pharmacol. Ther.
2015; Epub ahead of print.
12. Ferguson SK, Hirai DM, Copp SW, et al. Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular control in rats. J. Physiol.
2013; 591: 547–57.
13. Ferguson SK, Holdsworth CT, Wright JL, et al. Microvascular oxygen pressures in muscles comprised of different fiber types: Impact of dietary nitrate supplementation. Nitric Oxide
. 2015; 48: 38–43.
14. Fulford J, Winyard PG, Vanhatalo A, Bailey SJ, Blackwell JR, Jones AM. Influence of dietary nitrate supplementation on human skeletal muscle metabolism and force production during maximum voluntary contractions. Pflugers Arch.
2013; 465: 517–28.
15. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am. J. Clin. Nutr.
2000; 71: 1033–47.
16. Hernández A, Schiffer TA, Ivarsson N, et al. Dietary nitrate increases tetanic [Ca2+
]i and contractile force in mouse fast-twitch muscle. J. Physiol.
2012; 590: 3575–83.
17. Johnson MA, Polgar J, Weightman D, Appleton D. Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J. Neurol. Sci.
1973; 18: 111–29.
18. Jones AM. Influence of dietary nitrate on the physiological determinants of exercise performance: a critical review. Appl. Physiol. Nutr. Metab.
2014; 39: 1019–28.
19. Kelly J, Vanhatalo A, Bailey SJ, et al. Dietary nitrate supplementation: effects on plasma nitrite and pulmonary O2
uptake dynamics during exercise in hypoxia and normoxia. Am. J. Physiol. Regul. Integr. Comp. Physiol.
2014; 307: R920–30.
20. Koga S, Rossiter HB, Heinonen I, Musch TI, Poole DC. Dynamic heterogeneity of exercising muscle blood flow and O2
utilization. Med. Sci. Sports. Exerc.
2014; 46: 860–76.
21. Krustrup P, Söderlund K, Mohr M, Bangsbo J. The slow component of oxygen uptake during intense, sub-maximal exercise in man is associated with additional fibre recruitment. Pflugers Arch.
2004; 447: 855–66.
22. Larsen FJ, Schiffer TA, Borniquel S, et al. Dietary inorganic nitrate improves mitochondrial efficiency in humans. Cell Metab.
2011; 13: 149–59.
23. Larsen FJ, Weitzberg E, Lundberg JO, Ekblom B. Effects of dietary nitrate on oxygen cost during exercise. Acta Physiol. (Oxf)
. 2007; 191: 59–66.
24. Lundberg JO, Weitzberg E. NO generation from inorganic nitrate and nitrite: role in physiology, nutrition and therapeutics. Arch. Pharm. Res.
2009; 32: 1119–26.
25. Masschelein E, Van Thienen R, Wang X, Van Schepdael A, Thomis M, Hespel P. Dietary nitrate improves muscle but not cerebral oxygenation status during exercise in hypoxia. J. Appl. Physiol
. 2012; 113: 736–45.
26. McDonough P, Behnke BJ, Padilla DJ, Musch TI, Poole DC. Control of microvascular oxygen pressures in rat muscles comprised of different fibre types. J. Physiol.
2005; 563: 903–13.
27. Muggeridge DJ, Howe CC, Spendiff O, Pedlar C, James PE, Easton C. A single dose of beetroot juice enhances cycling performance in simulated altitude. Med. Sci. Sports. Exerc.
2014; 46: 143–50.
28. Muggeridge DJ, Howe CC, Spendiff O, Pedlar C, James PE, Easton C. The effects of a single dose of concentrated beetroot juice on performance in trained flatwater kayakers. Int. J. Sport Nutr. Exerc. Metab.
2013; 23: 498–506.
29. Peeling P, Cox GR, Bullock N, Burke LM. Beetroot juice improves on-water 500 m time-trial performance, and laboratory-based paddling economy in national and international-level kayak athletes. Int. J. Sport Nutr. Exerc. Metab.
2015; 25: 278–84.
30. Poole DC, Jones AM. Oxygen uptake kinetics. Compr. Physiol.
2012; 2: 933–6.
31. Porcelli S, Ramaglia M, Bellistri G, et al. Aerobic fitness affects the exercise performance responses to nitrate supplementation. Med. Sci. Sports Exerc.
2015; 47: 1643–51.
32. Richardson RS, Noyszewski EA, Leigh JS, Wagner PD. Lactate efflux from exercising human skeletal muscle: role of intracellular PO2
. J. Appl. Physiol
. 1998; 85: 627–34.
33. Tesch PA, Thorsson A, Kaiser P. Muscle capillary supply and fiber type characteristics in weight and power lifters. J. Appl. Physiol. Respir. Environ. Exerc. Physiol.
1984; 56: 35–8.
34. Thompson C, Wylie LJ, Fulford J, et al. Dietary nitrate improves sprint performance and cognitive function during prolonged intermittent exercise. Eur. J. Appl. Physiol.
2015; 115: 1825–34.
35. Umbrello M, Dyson A, Feelisch M, Singer M. The key role of nitric oxide in hypoxia: hypoxic vasodilation and energy supply-demand matching. Antioxid. Redox. Signal
. 2013; 19: 1690–710.
36. Vanhatalo A, Bailey SJ, Blackwell JR, et al. Acute and chronic effects of dietary nitrate supplementation on blood pressure and the physiological responses to moderate-intensity and incremental exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol.
2010; 299: 1121–31.
37. Vanhatalo A, Bailey SJ, DiMenna FJ, Blackwell JR, Wallis GA, Jones AM. No effect of acute l-arginine supplementation on O2
cost or exercise tolerance. Eur. J. Appl. Physiol.
2013; 113: 1805–19.
38. Vanhatalo A, Fulford J, Bailey SJ, Blackwell JR, Winyard PG, Jones AM. Dietary nitrate reduces muscle metabolic perturbation and improves exercise tolerance in hypoxia. J. Physiol.
2011; 589: 5517–28.
39. Vanhatalo A, Jones AM, Blackwell JR, Winyard PG, Fulford J. Dietary nitrate accelerates postexercise muscle metabolic recovery and O2 delivery in hypoxia. J. Appl. Physiol.
2014; 117: 1460–70.
40. Wylie LJ, Bailey SJ, Kelly J, Blackwell JR, Vanhatalo A, Jones AM. Influence of beetroot juice supplementation on intermittent exercise performance. Eur. J. App. Physiol.
2016; 116: 415–25 in press.
41. Wylie LJ, Kelly J, Bailey SJ, et al. Beetroot juice and exercise: pharmacodynamic and dose-response relationships. J. Appl. Physiol
. 2013; 115: 325–36.
42. Wylie LJ, Mohr M, Krustrup P, et al. Dietary nitrate supplementation improves team sport–specific intense intermittent exercise performance. Eur. J. Appl. Physiol.
2013; 113: 1673–84.